Mariner, LLC Edwards Lifesciences Corp Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mariner, LLC holds 148,535 shares of EW stock, worth $9.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

148,535

Previous 165,143 10.06%

Holding current value

$9.73 Million

Previous $15.8 Million 13.06%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $1.4 Million - $1.57 Million	-16,608 Reduced 10.06%	148,535 $13.7 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $461,717 - $608,239	6,365 Added 4.01%	165,143 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $225,550 - $284,212	3,655 Added 2.36%	158,778 $12.1 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $21,199 - $28,574	-306 Reduced 0.2%	155,123 $10.7 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $547,238 - $634,086	-6,722 Reduced 4.15%	155,429 $14.7 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $224,933 - $255,980	3,029 Added 1.9%	162,151 $13.4 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $2.95 Million - $3.78 Million	-43,184 Reduced 21.35%	159,122 $11.9 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $913,153 - $1.19 Million	11,086 Added 5.8%	202,306 $16.7 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.24 Million - $1.83 Million	-14,281 Reduced 6.95%	191,220 $18.2 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $4.37 Million - $5.5 Million	42,884 Added 26.37%	205,501 $24.2 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $2.58 Million - $3.17 Million	-24,246 Reduced 12.98%	162,617 $21.1 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $2.29 Million - $2.73 Million	22,248 Added 13.52%	186,863 $21.2 Million
Q2 2021 Aug 24, 2021	BUY	$83.84 - $104.76 $321,861 - $402,173	3,839 Added 2.39%	164,615 $17 Million
Q1 2021 May 07, 2021	SELL	$78.68 - $90.67 $297,961 - $343,367	-3,787 Reduced 2.3%	160,776 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $185,963 - $236,650	2,594 Added 1.6%	164,563 $15 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $412,680 - $537,056	6,142 Added 3.94%	161,969 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $6.02 Million - $8.05 Million	104,648 Added 204.47%	155,827 $10.8 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $204,975 - $316,791	3,911 Added 8.27%	51,179 $9.66 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $487,416 - $558,047	6,798 Added 16.8%	47,268 $11 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $96,879 - $118,726	-1,574 Reduced 3.74%	40,470 $8.9 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $169,449 - $195,806	3,040 Added 7.79%	42,044 $7.77 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $1.38 Million - $1.85 Million	28,880 Added 285.26%	39,004 $7.46 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $124,471 - $152,713	-2,682 Reduced 20.94%	10,124 $1.55 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $228 - $290	-5 Reduced 0.04%	12,806 $2.23 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $21,394 - $25,855	-504 Reduced 3.79%	12,811 $1.87 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $60,433 - $77,106	-1,625 Reduced 10.88%	13,315 $1.86 Million
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $110,628 - $128,962	3,274 Added 28.06%	14,940 $1.68 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $423,359 - $452,990	11,666	11,666 $1.28 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account